Skip to main content

Redx announces the launch of third subsidiary

Redx announces the launch of third subsidiary

Manchester-based Seneca EIS portfolio company Redx, the drug discovery and development company, has announced the launch of its third subsidiary, Redx Immunology, which will focus on developing new therapies for disorders of the immune system.

Redx Immunology will deliver up to eight new drug development candidates over the near to medium term for progression into clinical trials.

Redx Immunology will operate at Redx’s laboratories at Alderley Park, Cheshire and is being launched using the proceeds from the Company’s recent IPO together with the matched funding from the Group’s £4.2 million grant award from the UK Government’s Regional Growth Fund (“RGF”).

See the article in full at